Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OPPS Proposal Delayed As 70% Pro-Rata Reduction Finds Critics On The Hill

This article was originally published in The Gray Sheet

Executive Summary

A pro-rata reduction exceeding 70% in Medicare "pass-through" payments, expected to be included in CMS' outpatient prospective payment system (OPPS) proposed rule, is preventing timely release of the document.

You may also be interested in...



OPPS Final Rule Shifts 75% To APC Base; “Outlier” Fix Legislation Likely

CMS' Nov. 1 final rule on the outpatient prospective payment system (OPPS) provides less than the dollar-for-dollar shift from the "pass-through" payments to the ambulatory payment classification (APC) base that had been sought by the device industry

OPPS Final Rule Shifts 75% To APC Base; “Outlier” Fix Legislation Likely

CMS' Nov. 1 final rule on the outpatient prospective payment system (OPPS) provides less than the dollar-for-dollar shift from the "pass-through" payments to the ambulatory payment classification (APC) base that had been sought by the device industry

Industry, Hospital Groups Clash Over Future Of OPPS Outlier Provision

The American Hospital Association urges the Centers for Medicare & Medicaid Services in Oct. 2 comments to avoid changes to the hospital outpatient prospective payment (OPPS) system's "outlier" provision.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015254

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel